Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - fluconazole - solution for infusion - 2 mg/ml - triazole derivatives

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - fluconazole - solution for infusion - 2 mg/ml - triazole derivatives

Israel - English - Ministry of Health

boehringer ingelheim israel ltd. - ipratropium bromide - respirator solution - ipratropium bromide 0.25 mg/ml - ipratropium bromide - ipratropium bromide - for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema . aerovent respirator solution is of particular benefit in relieving acute bronchospasm when used concomitantly with inhaled beta agonists.

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol - solution - 0.5 mg/2.5 ml - ipratropium bromide monohydrate 0.52mg/2.5ml eqv. to ipratropium bromide anhydrous 0.5 mg/2.5 ml; salbutamol sulphate 3.01mg/2.5ml eqv. to salbutamol 2.500 mg/2.5 ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - iopamidol - injection - 6.12 g/10 ml - iopamidol 6.12 g/10 ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - iopamidol - injection - 7.55 g/10 ml - iopamidol 7.55 g/10 ml

Singapore - English - HSA (Health Sciences Authority)

gilead sciences singapore pte. ltd. - emtricitabine; tenofovir disoproxil 245mg equivalent to tenofovir disoproxil fumarate - tablet, film coated - 200mg - emtricitabine 200mg; tenofovir disoproxil 245mg equivalent to tenofovir disoproxil fumarate 300mg

United States - English - NLM (National Library of Medicine)

american health packaging - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 2 mg - tolterodine tartrate extended-release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see clinical studies (14) ]. tolterodine tartrate extended-release capsules are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate extended-release capsules are also contraindicated in patients with known hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate extended-release capsules, are metabolized to 5-hydroxymethyl tolterodine [see warnings and precautions (5.2), (5.3), (5.4) ]. risk summary there are no available data with tolterodine tartrate extended-release capsules use in pregnant women to inform drug-associated risks. in animal reproduction studies, oral administration of tolterodine and its 5-hmt metabolite to pregnant mice during organogenesis di